Hydralazine-induced lupus without kidney involvement
A 45-year-old woman with stage 3 CKD has had hypertension well controlled for 3 years on lisinopril, chlorthalidone, and hydralazine. She reports 4 months of malaise, low-grade fevers, and arthralgias. Temperature is 38.2°C. She has diffuse muscle tenderness without joint swelling and a faint maculopapular rash on her arms and torso. Creatinine is 1.4 mg/dL (1.6 two years ago); C3 120 and C4 39 mg/dL; ANA <1:80 (≤1:40); anti-dsDNA 0 IU/mL; anti-histone antibodies 1:32 (<1:16); MPO-ANCA 3 U (<1); PR3-ANCA 0.3 U (<1). Urinalysis is negative for protein and blood. What is the best next step?
- A.Discontinue hydralazineCorrect
- B.Obtain kidney biopsy
- C.Obtain blood cultures
- D.Prescribe methylprednisolone
Explanation
The next best step is to discontinue hydralazine. After 3 years of hydralazine, this woman has 4 months of malaise, low-grade fever, arthralgias, myalgias, and a rash, with a positive ANA, positive anti-histone antibodies, negative anti–double-stranded DNA antibodies, normal complements, and a low-titer positive MPO-ANCA. This is the profile of hydralazine-induced lupus. Hydralazine is metabolized by hepatic N-acetylation, and slow acetylators, cumulative doses above about 100 g, female sex, and HLA-DR4 increase risk. Hydralazine can also cause drug-induced ANCA-associated vasculitis, often with high-titer MPO-ANCA, multiple autoantibodies (ANA, anti-histone, sometimes anti-dsDNA), low complements, and pauci-immune necrotizing glomerulonephritis. Her urinalysis shows no blood or protein, and her creatinine is stable compared with 2 years ago, so there is no evidence of glomerulonephritis. The essential first step for any hydralazine-associated autoimmune syndrome is withdrawal of the drug, which leads to resolution of drug-induced lupus over weeks to months; a substitute antihypertensive can be chosen. ANCA titers and urinalysis should be monitored, because new hematuria, proteinuria, or rising creatinine would signal kidney involvement. Kidney biopsy is indicated for suspected hydralazine-associated vasculitis with active urinary sediment, proteinuria, or declining function. With a bland urinalysis and stable creatinine, a biopsy would carry risk without diagnostic benefit. Methylprednisolone or other glucocorticoids are reserved for severe drug-induced lupus that persists after withdrawal, or for hydralazine-associated vasculitis with organ-threatening disease. Mild constitutional and musculoskeletal symptoms usually resolve after stopping the drug, sometimes with NSAIDs or low-dose prednisone, which are cautious choices in CKD. Blood cultures are reasonable when fever suggests infection, particularly endocarditis, which can also produce ANCA positivity. However, her 4-month course, absence of a murmur or sick contacts, and the serologic profile point to a drug reaction, and cultures do not replace stopping the culprit drug.
Why each option
- A.
- Correct. Fever, arthralgia, myalgia, rash, anti-histone antibodies, negative anti-dsDNA, and normal complements after years of hydralazine indicate drug-induced lupus, treated by withdrawal.
- B.
- Biopsy is warranted only with hematuria, proteinuria, or declining function; her bland urinalysis and stable creatinine show no evidence of glomerulonephritis.
- C.
- Cultures help when fever suggests endocarditis, but a 4-month course without murmur and a classic drug-induced lupus serologic profile point to hydralazine.
- D.
- Glucocorticoids are reserved for drug-induced lupus persisting after withdrawal or organ-threatening hydralazine vasculitis; mild symptoms usually resolve once the drug stops.
Reference: Kumar B, Semin Arthritis Rheum 2018 (hydralazine-associated vasculitis); KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis
This is one of 1,100 questions in the MedBoardSA nephrology bank, with timed test mode, tutor mode, and progress tracking by topic.
Practise the full bankBrowse other topics
- Electrolyte Disorders (15)
- CKD Management (12)
- AKI (11)
- Transplant (10)
- Primary GN (9)
- HTN (8)
- Secondary GN (7)
- Hemodialysis (7)
- Genetic GN (3)
- Diabetic Nephropathy (3)
- Peritoneal Dialysis (3)
- Nephrolithiasis (3)
- CKD Bone Disease (2)
- Calcium Metabolism (2)
- Dysproteinemias (1)
- Secondary HPT (1)
- Phosphate & FGF23 (1)
- Calciphylaxis (1)